Table 1.
Group | Leukocyte (no./mm3) | Neutrophils (%) | Monocytes (%) | Lymphocytes (%) |
---|---|---|---|---|
Control | 4768.57 ± 389.12 | 54.43 ± 3.69 | 1.86 ± 0.90 | 23.43 ± 5.16 |
Inflammation | 8840.00 ± 1227.44 | 72.00 ± 3.51 | 1.57 ± 0.79 | 23.14 ± 3.67 |
Meloxicam | 4794.29 ± 669.05 | 62.14 ± 4.91 | 1.86 ± 1.07 | 21.14 ± 2.85 |
1 | 8057.50 ± 503.08 | 60.57 ± 2.23 | 1.71 ± 0.49 | 22.71 ± 3.50 |
2 | 8810.00 ± 653.57 | 68.57 ± 4.86 | 1.43 ± 0.79 | 19.14 ± 1.95 |
3 | 10,260.00 ± 522.11 | 72.43 ± 3.21 | 1.86 ± 0.90 | 18.86 ± 3.02 |
4 | 10,382.00 ± 649.36 | 76.00 ± 2.65 | 1.71 ± 0.95 | 20.43 ± 4.69 |
5 | 10,432.86 ± 656.93 | 78.17 ± 5.31 | 1.57 ± 0.53 | 22.86 ± 3.24 |
6 | 4684.00 ± 643.96 | 56.14 ± 4.74 | 1.43 ± 0.79 | 25.71 ± 4.19 |
7 | 6652.00 ± 945.79 | 68.67 ± 3.93 | 1.71 ± 0.76 | 25.43 ± 2.23 |
8 | 6725.00 ± 658.91 | 62.40 ± 3.85 | 1.57 ± 0.53 | 25.14 ± 2.73 |
9 | 6850.00 ± 771.36 | 71.71 ± 4.39 | 1.29 ± 0.49 | 22.14 ± 3.39 |
10 | 6367.14 ± 766.23 | 66.43 ± 6.40 | 1.71 ± 0.76 | 20.71 ± 2.36 |
11 | 3796.67 ± 738.12 | 52.00 ± 3.27 | 1.57 ± 0.79 | 23.43 ± 3.05 |
12 | 10,425.00 ± 693.42 | 67.57 ± 2.30 | 1.57 ± 0.79 | 22.71 ± 2.98 |
13 | 9677.50 ± 521.94 | 73.33 ± 7.31 | 1.86 ± 0.69 | 18.57 ± 1.51 |
14 | 9881.67 ± 794.06 | 72.80 ± 3.56 | 1.29 ± 0.49 | 24.29 ± 4.03 |
15 | 9995.00 ± 552.66 | 60.29 ± 3.9 | 1.57 ± 0.53 | 23.14 ± 4.88 |
16 | 3275.00 ± 861.68 | 52.00 ± 4.2 | 1.43 ± 0.79 | 22.86 ± 1.86 |
17 | 3922.86 ± 412.54 | 51.29 ± 4.5 | 1.71 ± 0.49 | 21.29 ± 5.25 |
18 | 3440.00 ± 716.87 | 49.86 ± 2.97 | 1.43 ± 0.53 | 18.00 ± 2.00 |
19 | 3037.14 ± 454.41 | 48.71 ± 2.98 | 1.57 ± 0.53 | 19.14 ± 2.19 |
All experiments were performed in triplicates. Results are expressed as means ± standard deviation.